Objective To explore the Lyophilizing Thrombin Powder combined with omeprazole in the treatment of peptic ulcer hemorrhage on clinical effect and influence on the change of the original level of the fiber protein.Methods118 cases of peptic ulcer bleeding from Yongkang Hospital were enrolled in this study, according to the order of hospitalization will be divided into observation group and control group.The control group were only given omeprazole and other conventional treatment;patients in the observation group was combined with Lyophilizing Thrombin Powder for treatment.The clinical treatment effect were compared between the two groups before and after treatment, compared two groups of patients with changes in fibrinogen levels.ResultsAfter treatment, the total efficiency rate of observation group was 91.07%, the total effective rate of control group was 75.81%, there was significant difference between two groups (P<0.05).Before treatment, two groups of patients with fibrinogen level was not statistically significant.With the treatment, the two groups of patients with fibrin the original level decreased, but the patients in the observation group decreased more significantly than the control group, the difference was statistically significant (P<0.05).ConclusionLyophilizing Thrombin Powder combined with omeprazole in the treatment of peptic ulcer bleeding effect significantly, can effectively reduce blood fibrinogen level, hemostasis, and its clinical use is safe and reliable, and is worth to popularize in clinic.
Objective To investigate the effects of recombinant human erythropoietin βinjection on levels of superoxide dismutase ( SOD ) , glutathione peroxidase ( GSH-PX ) , malondialdehyde ( MDA ) and homocysteine ( Hcy ) in patients with diabetic peritoneal dialysis.Methods 92 patients of parallel peritoneal dialysis in diabetic nephropathy who received therapy from September 2014 to September 2016 in our hospital were selected and randomly divided into the observation group and the control group with 46 cases in each group.The control group was treated with peritoneal dialysis routine treatment, while the observation group was treated with recombinant human erythropoietin βinjection on this basis.The levels of hemoglobin (Hb), hematocrit (Hct), renal function, SOD, GSH-PX, MDA and Hcy were compared.Results After treatment, the levels of Hb and Hct in the observation group were higher than the control group, the difference was statistically significant (P<0.05), the urinary albumin excretion rate (UAER) and serum creatinine (SCr) in the observation group were lower than the control group, the difference was statistically significant (P<0.05), the levels of SOD and GSH-PX in the observation group were higher than the control group, the levels of MDA and Hcy were lower the control group, the difference was statistically significant (P<0.05).Conclusion The effect of recombinant human erythropoietin βinjection on diabetic nephropathy patients with peritoneal dialysis was significant, which could improve the levels of SOD, GSH-PX, MDA and Hcy.
Objective To study and analyze the clinical effect of valsartan on chronic pulmonary heart disease. Methods 100 cases of heart failure patients with pulmonary heart disease treated in our hospital from January 2015 to October 2016 were selected and randomly divided into the control group and the experimental group,50 cases in each group.Two groups of patients were given the basic treatment of diuretics,low salt diet, digitalis and nitrates,so as to ensure that the patients had enough rest.Patients in the control group were treated with benazepril,and the patients in the experimental group were treated with valsartan.The clinical indexes of the experimental group and the control group were compared and analyzed. Results After corresponding treatment,the number of effective treatment was 48 cases.In the control group,the total effective number was 41 cases. The effective rate of the control group (82.0％) was significantly lower than the experimental group(96.0％) (P<0.05).The incidence of adverse reactions in the experimental group was 8.0％, and the fatality rate was 10.0％. The incidence of adverse reactions in the control group was 10.0％, and the fatality rate was 12.0％.There was no significant difference between two groups.After treatment,the indexes of LVEDD and LVESD in the experimental group were better than those in the control group,with statistical significance(P<0.05).Conclusion Valsartan was effective in the treatment of chronic pulmonary heart disease with heart failure.It can improve the treatment efficiency and security in a certain extent,and has the significance of further popularization and application.
Objective To investigate the prevention effect of Ezetimibe with loaded dose on hematologic parameters and re-infarction in patients undergoing PCI.Methods 240 cases of patients with non ST segment elevation myocardial infarction performed PCI from October 2012 to October 2014 were selected and randomly divided into two groups,the control group received conventional dose Ezetimibe 10 mg every time,qd,the study group received loading dose ezetimibe 20 mg every time, qd, both two groups treatment 30 days.The inflammatory factors, myocardial injury and vascular endothelial function were compared before, 24 h and 30 d after the operation, and patients were followed up for two years,record adverse reactions. Results Compared with before treatment,levels of serum inflammatory factor,myocardial injury and vascular endothelial function index in different time points had differences by single factor analysis of variance(P<0.05),and compared with the control group, levels of serum hs-CRP,TNF-α,IFN-γand IL-6 in the study group were lower, levels of serum CK-MB,cTnI and BNP were lower,the contents of ET in serum were lower,and the contents of NO were higher(P<0.05).The improvement degree in the study group of myocardial microcirculation perfusion after treatment was higher(P<0.05).No case shedding phenomenon occurred during the two year follow-up, and there was no statistical significance in the incidence of cardiovascular events between two groups.Conclusion Loading dose of ezetimibe can protect myocardium,and it can inhibit the inflammatory reaction and vascular endothelial injury caused by operation,it also can improve myocardial microcirculation.
Objective To compare the anti-tumor activity and antioxidant activity of ethanol extracts of F.veluties and A.auricula.Methods Three human carcinoma cell lines, including MCF-7, HeLa and A375 were assessed by MTT assay to measure cell viability.The antioxidant activity was detected with a DPPH and RFAP assays.Results Two domestic fungus have different anti-tumor activity on the inhibition of MCF-7, HeLa and A375 cells at 25-400μg/mL concentration rage.F.velutipes was better than the A.auricula.The difference was statistically significant ( P<0.05 ).Compared with the control group, the inhibition of F.velutipes were 48.20%, 52.61%and 50.58%at the concentration of 400μg/mL, respectively (P<0.01).At the same concentration, the inhibition of A.auricula were 37.62%、50.21%and 41.59%, respectively (P<0.01).The ethanol extracts of two domestic fungus have significant antioxidant activity.F.velutipes was better than the A.auricula.The difference was statistically significant ( P<0.01 ).Compared with the control group, the scavenging radical capacities on DPPH of ethanol extracts of F.velutipes and A.auricula were 60.30%and 40.43%at the concentration of 1.6 mg/mL, respectively (P<0.01).At the same concentration FRAP value were 9.5 and 7.0 mmol/mL(P<0.01).Conclusion The F.velutipes and A.auricula both have strong anti-tumor and antioxidant activities, F.velutipes is better than A.auricula.
Objective To analyse the effect of Danhong injection on serum levels of cystatin C (CysC), homocysteine (Hcy) and inflammatory factors in elderly patients with chronic heart failure.Methods Fifty-two elderly patients who were diagnosed with chronic heart failure in our hospital were collected.All patients were randomly divided into experimental group and control group, 26 cases in each group, the control group were given conventional therapy, the experimental group received Danhong injection adjunctive therapy on the basis of the control group.After treatment, the serum levels of CysC, Hcy, nuclear transcription factorκB (NF-κB), interleukin-1β(IL-1β), tumor necrosis factor-α(TNF-α), heart function and incidence of adverse reactions were detected in all patients.Results After treatment, compared with control group, the serum levels of CysC and Hcy were lower, the serum levels of NF-κB,IL-1βand TNF-αwere lower in the experimental group, and the levels of left ventricular ejection fraction ( LVEF) and stroke volume (SV) were lower in the experimental group, there were significant difference between two groups (P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups.Conclusion The Danhong injection therapy could significantly reduce the serum levels of CysC, Hcy and inflammatory factors in elderly patients with chronic heart failure,reduce the inflammatory reaction, improve the heart function, and have high safety.
目的 探讨头孢哌酮舒巴坦联合雾化吸入治疗慢性阻塞性肺疾病患者急性加重期的疗效及对肺功能的影响.方法 选取我院2016年5月～2017年6月收治的慢性阻塞性肺疾病患者58例为研究对象.随机分为两组,各29例.对照组采用常规治疗方法,治疗组则采用头孢哌酮舒巴坦联合雾化吸入进行治疗.观察两组患者的临床疗效.结果 治疗组患者治疗后的PaO2值,高于对照组,差异有统计学意义(P＜0.05);治疗组治疗后的PaCO2值,低于对照组,差异有统计学意义(P＜0.05);治疗后治疗组的FEN、FVC,高于对照组;差异有统计学意义(P＜0.05).结论 对慢性阻塞性肺疾病患者采用头孢哌酮舒巴坦联合雾化吸入治疗,具有良好的效果,可有效改善患者的各项肺功能情况,值得应用于临床.
Polysaccharides are a class of natural macromolecules with biological activities which could regulate the immune system by activating immune cells and promoting the secretion of cytokines to exert the anti-tumor and anti-oxidation activities.The article reviews the mechanism of polysaccharides acting on the immune system and its anti-tumor immunotherapy applications.
目的 观察研究甲磺酸阿帕替尼片治疗晚期非小细胞肺癌的临床疗效.方法 选取86例晚期非小细胞肺癌,按随机数字表法分为观察组和对照组各43例,对照组给予紫杉醇单药化疗,观察组给予甲磺酸阿帕替尼片(艾坦)治疗,随访并记录2组患者癌胚抗原(CEA)、细胞角蛋白19片段(CYFRA21-1)、血管内皮生长因子(VEGF)、基质金属蛋白酶-9(MMP-9)以及疗效情况.结果 观察组患者治疗后肿瘤标志物癌胚抗原(CEA)、细胞角蛋白19片段(CYFRA21-1)值分别为(14.01±1.04、4.42±0.35) ng/mL,均优于对照组(18.05±1.86、18.05±1.86) ng/mL(P＜0.05).观察组患者治疗后血管内皮生长因子(VEGF)以及基质金属蛋白酶-9(MMP-9)值分别为(285.49±35.47 ng/L、1008.28±85.16 ng/mL),均优于对照组(494.82±50.16 ng/L、1459.54±119.75 ng/m L)(P＜0.05).观察组患者治疗后总有效率为95.35％,高于对照组76.74％ (P ＜0.05).结论 甲磺酸阿帕替尼片治疗晚期非小细胞肺癌的临床治疗效果确切,值得临床进一步研究和应用.
目的 观察研究尼妥珠单抗联合三维适形放射治疗晚期非小细胞肺癌的临·床疗效.方法 选取70例晚期非小细胞肺癌的患者,按随机数字表法分为观察组和对照组各35例,对照组给予三维适形放射治疗,观察组在予三维适形放射治疗基础上给予尼妥珠单抗治疗,随访并记录2组患者相关指标变化情况.结果 观察组患者治疗后血管内皮生长因子(VEGF)以及基质金属蛋白酶-9 (MMP-9)值分别为(274.96±37.69 ng/L、994.80±89.38 ng/mL),均优于对照组(485.49±47.19ng/L、1474.24±124.05 ng/mL) (P ＜0.05).观察组患者治疗后肿瘤标志物癌胚抗原(CEA)、细胞角蛋白19片段(CYFRA21-1)值分别为(9.35±1.07、4.41±0.52) ng/mL,均优于对照组(15.03±2.13、5.77±0.71) ng/mL(P＜0.05).观察组患者治疗后总有效率为91.43％,高于对照组65.71％(P＜0.05).结论 尼妥珠单抗联合三维适形放射治疗晚期非小细胞肺癌的临床治疗效果确切,值得临床进一步研究和应用.
目的 观察研究泮托拉唑钠肠溶胶囊治疗胃溃疡的临床疗效.方法 选取辽宁医学院附属第一医院肝胆减肥外科2013年8月～ 2014年8月收治疗的确诊为胃溃疡的患者共80例,按随机数字表法分为观察组和对照组各40例,对照组给予抗幽门螺杆菌治疗,观察组在对照组的基础上给予泮托拉唑钠肠溶胶囊治疗,随访并记录2组患者症状变化、幽门螺杆菌清除率及治疗效果情况.结果 治疗后,观察组患者胃胀胃痛、纳食减少、反吐酸水评分低于对照组(P＜0.05).观察组患者幽门螺杆菌清除率为97.14％明显高于对照组82.86％ (x2=3.914,P＜0.05).观察组患者治疗后总有效率为91.43％,高于对照组77.14％(x2=4.501,P＜0.05).结论 泮托拉唑钠肠溶胶囊治疗胃溃疡的临床治疗效果确切,无明显副反应.
目的 探讨孟鲁司特钠联合布地奈德混悬液对哮喘急性发作患儿C-反应蛋白,肺功能及临床疗效的影响.方法 收集湖州市中心医院儿科收治的支气管哮喘急性发作的患儿46例,随机分为对照组和实验组,每组各23例,2组均给予常规抗感染治疗,对照组给予氯雷他定片5 mg,1次/天,口服;给予硫酸特布他林雾化液1 mL,2次/天,雾化吸入;实验组给予孟鲁司特钠咀嚼片4mg,1次/天,口服;给予布地奈德混悬液1 mL+硫酸特布他林雾化液l mL,2次/天,雾化吸入.2组均治疗10d,治疗结束后,对所有患儿的血清C反应蛋白(C-reactive protein,CRP)、肺功能及临床疗效进行检测.结果 与对照组治疗后比较,实验组患儿的血清CRP水平较低(P＜0.05);实验组患儿的第1秒用力呼气容积/用力肺活量比值(forced expiratory volume in one second/forced vital capacity,FEV1/FVC％)、最大呼气峰流速(peak expiratory flow,PEF)水平较高(P＜0.05);实验组患儿的总有效率较高(P＜0.05).结论 孟鲁司特钠联合布地奈德混悬液能够显著降低哮喘急性发作患儿血清CRP水平,改善肺功能,具有良好的临床疗效.
Objective To explore the effect of Xiaoyao pill combined with low-dose corticosteroid on serum estrogens levels in the treatment of patients with menopause syndrome and its clinical efficacy.Methods 96 patients with menopause syndrome from April 2013 to February 2015 in department of obstetrics and gynecology of Lishui second people’s hospital were selected and divided into 2 groups according to a random number table, the control group (48 cases) were treated with small dose of hormone therapy, the treatment group (48 cases) were treated with Xiaoyao pill combined with small dose of hormone therapy.The serum estrogens levels, Kupperman score, endometrial thickness and clinical efficacy were compared. Results The total effective rate of control group(79.17%) was lower than that of treatment group(93.75%)(P<0.05).Compared with control group post-treatment, the serum follicle stimulating hormone (FSH) and luteinizing hormone (LH) levels were lower, estradiol (E2) level was higher, the Kupperman score was lower, the endometrial thickness was higher than those of control group, there were significant differences ( P <0.05 ) . Conclusion Xiaoyao pill combined with small dose of hormone could improve serum E2, FSH and LH levels in the treatment of patients with menopause syndrome with high security.
